These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 12498015)
41. Oral almotriptan: practical uses in the acute treatment of migraine. Dowson AJ Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532 [TBL] [Abstract][Full Text] [Related]
42. Eletriptan (relpax) for migraine. Med Lett Drugs Ther; 2003 Apr; 45(1155):33-4. PubMed ID: 12719695 [No Abstract] [Full Text] [Related]
43. Chiral separation of Frovatriptan isomers by HPLC using amylose based chiral stationary phase. Khan M; Viswanathan B; Rao DS; Reddy R J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):119-23. PubMed ID: 16962393 [TBL] [Abstract][Full Text] [Related]
44. [Spanish contribution to the clinical development of eletriptan: an analysis of controlled studies]. Pascual J; Leira R; Lainez JM; Liaño H; Díez-Tejedor E; Navarro A; Jiménez D; Ezpeleta D; Mateos V; Madrigal M; Palacios G; Neurologia; 2004 Oct; 19(8):414-9. PubMed ID: 15470580 [TBL] [Abstract][Full Text] [Related]
45. [Utilizing the strength(s) of rizatriptan 10 mg: cost effective against migraine attacks]. MMW Fortschr Med; 2009 Mar; 151(13):92-3. PubMed ID: 19504831 [No Abstract] [Full Text] [Related]
46. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy. Goadsby PJ; Yates R Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161 [TBL] [Abstract][Full Text] [Related]
47. Acute migraine treatment with rizatriptan in real world settings - focusing on treatment strategy, effectiveness, and behavior. Hu H; Kurth T; Cady R; Santanello N; Bigal ME Headache; 2009 Feb; 49 Suppl 1():S34-42. PubMed ID: 19161564 [TBL] [Abstract][Full Text] [Related]
48. [Migraine therapy--rapid and effective]. Göbel H Krankenpfl J; 2004; 42(7-10):236. PubMed ID: 15675398 [No Abstract] [Full Text] [Related]
49. [Triptans in migraine: a comparative review of pharmacology, pharmacokinetics]. Kato K No To Shinkei; 2004 Sep; 56(9):733-8. PubMed ID: 15552861 [No Abstract] [Full Text] [Related]
50. Ten years of rizatriptan: from development to clinical science and future directions. Hargreaves RJ; Lines CR; Rapoport AM; Ho TW; Sheftell FD Headache; 2009 Feb; 49 Suppl 1():S3-20. PubMed ID: 19161563 [TBL] [Abstract][Full Text] [Related]
51. [Triptans in migraine: from clinical view]. Manaka S No To Shinkei; 2004 Sep; 56(9):739-45. PubMed ID: 15552862 [No Abstract] [Full Text] [Related]
53. Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science. Bigal ME; Ferrari M; Silberstein SD; Lipton RB; Goadsby PJ Headache; 2009 Feb; 49 Suppl 1():S21-33. PubMed ID: 19161562 [TBL] [Abstract][Full Text] [Related]
54. A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future. Mannix LK Expert Opin Pharmacother; 2008 Apr; 9(6):1001-11. PubMed ID: 18377342 [TBL] [Abstract][Full Text] [Related]
55. Pathways to the best fit of triptans for migraine patients. Buzzi MG Cephalalgia; 2008 Sep; 28 Suppl 2():21-7. PubMed ID: 18715329 [TBL] [Abstract][Full Text] [Related]
56. [Triptane. Zolmitriptan--fast and effective in migraine]. Schmerz; 2003 Jan; 17(1):1p following 97. PubMed ID: 12638534 [No Abstract] [Full Text] [Related]